NGNE
Neurogene Inc
33.60$
+3.2%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 94.9% | 66.0% | 67.0% | 98.6% | 99.4% | 97.7% | 92.4% | 72.9% | 77.5% | 90.0% | 94.1% | 94.2% | |
| 36.0% | 34.9% | 20.9% | 47.2% | 99.1% | 97.3% | 91.5% | 69.5% | 75.1% | 66.6% | 40.7% | 36.0% | |
| 94.4% | 65.7% | 66.8% | 98.0% | 99.1% | 97.3% | 91.5% | 69.5% | 75.1% | 88.6% | 93.1% | 93.2% | |
| 0.2% | 0.0% | – | – | – | – | – | 0.8% | 0.9% | 0.3% | 0.2% | – | |
| – | – | – | – | – | – | – | 1.9% | 1.0% | 0.7% | – | – | |
| – | – | – | – | – | 0.4% | 0.2% | 0.1% | – | – | – | – | |
| 12.7% | 4.3% | 6.3% | 10.4% | 6.4% | 3.6% | 9.2% | 190.5% | 9.7% | 16.4% | 7.6% | 8.2% | |
| 12.6% | 4.2% | 6.2% | 9.9% | 6.0% | 3.2% | 3.7% | 10.7% | 6.1% | 10.3% | 4.5% | 5.7% | |
| – | – | – | – | – | 0.4% | 0.3% | 1.8% | 0.6% | 1.3% | 0.9% | 1.1% | |
| 1.8% | – | – | – | 0.9% | 1.1% | 0.6% | 5.5% | 0.6% | 1.2% | 0.4% | 0.7% | |
| 87.3% | 95.7% | 93.7% | 89.6% | 93.6% | 96.4% | 90.8% | -90.5% | 90.3% | 83.6% | 92.4% | 91.8% | |
| -215.9% | -98.2% | -96.0% | -179.9% | -296.4% | -203.7% | -158.1% | -94.2% | -138.0% | -84.1% | -78.1% | -122.2% | |
| 20.9% | 11.2% | 12.2% | 21.3% | 30.3% | 18.4% | 24.6% | 54.2% | 11.7% | 5.8% | 5.2% | 7.3% |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.